Skip to content Skip to menu

21st Annual Medicines Australia CEP Award Winners Announced

Wednesday, 7 March 2018

Media Release

Today, Medicines Australia recognises the Australian pharmaceutical industry’s commitment to training and supporting our highly skilled and dedicated Medical Representatives.

This mandatory program highlights the innovative pharmaceutical industry’s diligent commitment to ethical conduct.

The Medicines Australia Continuing Education Program has been in existence for over 45 years.

A total of 659 students commenced their CEP journey through the University of Tasmania in 2017.

The aim of the CEP is to educate company representatives to a recognised industry standard in order to provide health care professionals with accurate, balanced information in an ethical manner that will enhance the quality use of medicines.

These representatives of the innovative pharmaceutical industry have the important job of ensuring the dialogue between the companies who make the medicines and the doctors that prescribe them is productive, balanced and ethical.

Medicines Australia would like to congratulate the following CEP award recipients:

Code of Conduct – Outstanding Achievement Award
This award is presented to the candidate who achieves the highest mark in Program 1, the Code of Conduct Program.

Simon McErlane who was working with Alexion Pharmaceuticals

Continuing Education Program – Top Achievers
Winners in this category are students who achieve the highest aggregate marks in all five core Programs of the CEP.

  • John Seeto – Hahn Healthcare
  • Anwar Johnson – Novartis Pharmaceuticals
  • Shaynora Prasad – Previously Hahn Healthcare
  • Joshua Lennox – Hahn Healthcare
  • Marion Arnott – Mundipharma
  • Nina Clifford – Boehringer Ingelheim
  • Monica MacGregor – Sanofi
  • Luke Mirabilio – Hahn Healthcare
  • Briar Tietjens – Novartis Pharmaceuticals
  • Wynette Monserrat – Independent.

The 2017 University of Tasmania Prize for Excellence
A prize is awarded for each semester and is based on the level and quality of students’ reflective assignments, exam results, active learning and participation in a Program.

  • Jennilee Davidson – Boehringer Ingelheim
  • Katie Barrett – Servier Laboratories

Medicines Australia would like to congratulate these worthy award winners and recognise the achievements of the 205 graduates of the 2017 Continuing Education Program.


More information – Natalie Wimmer – 0450 728 660


As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at